Register an account to search through 14,000+ stocks! 

Ad

OGEN – Oragenics Inc

Ad

Not Compliant

—X—

Industry: Biotechnology & Medical Research | NYSE MKT

Oragenics Inc is not compliant with Shariah. The company’s financials fail all the five standards we check against.

Market cap: 31 MRev. Growth: 0%

AAOIFI ✗

Debt/MC0.98%
Non-Compliant Assets/MC%
Impure Income (incl. Interest)87.18%
Impure Income%
Interest Income87.18%
Total87.18%

S&P ✗

Debt/36 mo MC0.63%
Cash/36 mo MC56.34%
AR/36 mo MC%

DJIM ✗

Debt/24 mo MC0.49%
Cash/24 mo MC44.11%
AR/24 mo MC%

FTSE ✗

Debt/Assets1.07%
Cash/Assets96.58%
Cash&AR/Assets96.58%
Impure Income (incl. Interest)87.18%
Impure Income%
Interest Income87.18%
Total87.18%

MSCI ✗

Debt/Assets1.07%
Cash/Assets96.58%
Cash&AR/Assets96.58%

Recommendation Rating

2

1

2

3

4

5

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 2.25

Low: 2.25

High: 2.25

Total Analysts: 1


Oragenics, Inc. is a development-stage company that is focused on fighting infectious diseases, including coronaviruses and multidrug-resistant organisms. The Company’s lead product, NT-CoV2-1, is an intranasal immunization vaccine candidate to prevent COVID-19 and variants of the SARS-CoV-2 virus. Its other product candidates include Terra CoV-2 and Antibiotics. Terra CoV-2 is an intramuscular vaccine candidate (plasmid + adjuvant) to provide long-lasting immunity against SARS-CoV-2. Antibiotics is a semi-synthetic analogs of MU1140, which is a member of lantibiotic class of antibiotics. The Company, through its wholly owned subsidiary, Noachis Terra, Inc. (Noachis Terra), is engaged in the research and development of its Terra CoV-2 and NT-CoV2-1 vaccine product candidates. It is also developing semi-synthetic lantibiotic analogs that may be effective against systemic Gram-positive multidrug infections, and analogs that may be effective in treating Gram negative infections.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan.

To understand how the screening is done, please read the Shariah Screening Methodology page.

Ad

Responses

  1. Assalam u alaikum I see that this stock non sharia complaint on other apps like islamicly. Could you please provide details information like this stock is halal or not ? As it fails one of the 3 components. Would highly appreciate if you could provide detailed information as how this stock could be considered halal

    1. Walaikum assalam wa rahmatullah
      So the problem with this company is that it has a lot of cash. Other screeners use a specific methodology which check and measure against cash. We screen against three different standards and this is why you will see that the stock has passed one or two standards but not others.

  2. Okie I have invested in this company an year ago, currently its under the value i purchased. I am eligible to take any profits in future if this stock price increases considering it to be halal. Sorry for too many questions. It is just that I want to be crystal clear. Jazak Allah for your quick response brother. May Allah reward you for this.

    1. If you are planning to hold it for a year, wait and see. Their cash levels may come down and they won’t be a problematic company in sha Allah. There’s no need to be in a hurry to sell if you believe it has good potential in the future. Some standards like the Indonesian one do not screen for Cash. Wait and see, I would say. But of course it’s your call, please do your research 🙂